Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 VHH BispecificAntibody (Bibody)
Recombinant Anti-CD64 x Anti-HER2 VHH BispecificAntibody (Bibody) (CAT#: BIBD-394)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Bibody) is a Fab-VHH format that uses heterodimeric Fab as a scaffold, and a VHH region linked to one of its heavy (Fd) or light (L) chain. The VHH of the anti-HER2 specificity is fused to the anti-CD64 heavy or light chain of the Fab. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 VHH BispecificAntibody (Bibody) (BIBD-394). Click the button below to contact us or submit your feedback about this product.